Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

February 1, 2006Open Access

Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This large series describes patterns of antigen expression in melanoma and their evolution over time. This will help inform decisions about selection of patients and target antigens for melanoma immunotherapy clinical trials.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Barrow et al. (Wed,) studied this question.

synapsesocial.com/papers/69df3e28de200760a8614b79 https://doi.org/https://doi.org/10.1158/1078-0432.ccr-05-1544

Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage | Synapse

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies.1994 · 90 citations
2A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.

1995 · 575 citations

3Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.1997 · 191 citations

4Expression of <i>MAGE</i> genes in primary and metastatic cutaneous melanoma1995 · 285 citations

5Antigens recognized by T-lymphocytes on human tumours1997 · 25 citations